Drugs / UK-396,082
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01091532 | Mar → Jul 2010 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UK-396,082 | “A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.” NCT01091532 ↗ |
| Modality | Small molecule | — CHEMBL398110 ↗ |
| Route | Oral | “100mg given orally twice daily for 14 days” NCT01091532 ↗ |